Beam Therapeutics

10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
clinical trials
Beam Therapeutics
Moderna Therapeutics
Pfizer
Sanofi
Gilead Sciences
JNJ
Amylx
Roche
Alnylam Pharmaceuticals
Vertex Pharmaceuticals
Lilly buys Beam’s option on Verve drug programs
Pharmaforum
Tue, 10/31/23 - 10:06 am
Eli Lilly
gene editing
Beam Therapeutics
Verve Therapeutics
Beam Therapeutics to cut 20% of workforce as part of restructuring plan
Reuters
Thu, 10/19/23 - 10:04 am
Beam Therapeutics
layoffs
sickle cell disease
AATD
Beam Therapeutics starts dosing in phase 1/2 trial of BEAM-201 in relapsed, refractory T-ALL/T-LL
Benzinga
Tue, 09/5/23 - 11:28 am
Beam Therapeutics
clinical trials
CAR-T
BEAM-201
T-ALL
T-LL
Gene Editing Therapeutics Could Hit the Market in 2023
BioSpace
Mon, 04/10/23 - 11:32 am
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia Therapeutics
Editas Medicine
Beam Therapeutics
A stealth biotech startup is quietly advancing a new drugmaking tool from David Liu’s lab
BioPharma Dive
Wed, 04/5/23 - 07:22 pm
startups
biotech
Beam Therapeutics
Prime Medicine
Resonance Medicine
David Liu
Beam jumps back into off-the-shelf CAR-T race after FDA lifts clinical hold
Fierce Biotech
Fri, 12/2/22 - 11:03 am
Beam Therapeutics
FDA
CAR-T
clinical trials
BEAM-201
Beam-linked startup launches with an eye on the next generation of RNA drugs
BioPharma Dive
Wed, 09/7/22 - 10:24 am
Orbital Therapeutics
Beam Therapeutics
RNA
R&D
Beam details reasons for FDA hold on base editing cancer therapy
BioPharma Dive
Thu, 09/1/22 - 10:29 am
Beam Therapeutics
FDA
gene editing
cancer
Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold
Endpoints
Tue, 08/30/22 - 11:50 am
Beam Therapeutics
FDA
CAR-T
FDA halts testing of Beam’s base editing cancer therapy
BioPharma Dive
Mon, 08/1/22 - 10:45 am
Beam Therapeutics
clinical trials
FDA
gene editing
CRISPR
Why Pfizer's Deal With Beam Therapeutics Is a Smart Move
Motley Fool
Mon, 01/24/22 - 10:12 am
Pfizer
Beam Therapeutics
gene editing
Pfizer expands into gene editing with Beam research deal
BioPharma Dive
Mon, 01/10/22 - 11:30 am
Pfizer
Beam Therapeutics
MRNA
gene editing
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
Tue, 08/10/21 - 11:12 pm
M&A
Bayer
Sanofi
Amgen
uniQure
MorphoSys
Xeris Pharmaceuticals
Relay Therapeutics
Merck
Beam Therapeutics
Jazz Pharmaceuticals
2 Winners for a Drug Development Future That Looks Nothing Like the Past
Motley Fool
Fri, 06/4/21 - 10:44 am
genomics
Pacific Biosciences
Beam Therapeutics
Gene editing biotech Beam adds to drug delivery stable with $120M GuideTx buy
Fierce Biotech
Tue, 02/23/21 - 10:51 am
Beam Therapeutics
gene editing
drug delivery
Beam, Verve stockpile cash as investors bank on gene editing progress
BioPharma Dive
Tue, 01/19/21 - 09:13 pm
Beam Therapeutics
Verve Therapeutics
gene editing
funding
This Startup Might Finally Cure Sickle Cell Disease—After A Century Of Racist Neglect
Forbes
Fri, 07/10/20 - 10:54 am
Beam Therapeutics
sickle cell disease
racism
Magenta, Beam partner to explore use of antibody-based conditioning drug for gene therapies
MedCity News
Mon, 06/15/20 - 10:25 am
Magenta Therapeutics
Beam Therapeutics
MGTA-117
gene therapy
sickle cell disease
beta thalassemia
Covid-19 stalls biotech flotations
EP Vantage
Fri, 04/10/20 - 10:26 am
COVID-19
IPOs
Revolution Medicines
Black Diamond Therapeutics
Passage Bio
Beam Therapeutics
Schrödinger

Pages